{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:32:28Z","timestamp":1715988748308},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.pnpbp.2012.05.005","type":"journal-article","created":{"date-parts":[[2012,5,31]],"date-time":"2012-05-31T09:12:12Z","timestamp":1338455532000},"page":"52-56","source":"Crossref","is-referenced-by-count":12,"title":["The reduction of superoxide dismutase activity is associated with the severity of neurological soft signs in patients with schizophrenia"],"prefix":"10.1016","volume":"39","author":[{"given":"Monia","family":"Raffa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiraz","family":"Fendri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Ben Othmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9la","family":"Slama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montassar","family":"Amri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelhamid","family":"Kerkeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anwar","family":"Mechri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pnpbp.2012.05.005_bb0005","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0278-5846(02)00220-8","article-title":"The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant\/antioxidant imbalance","volume":"26","author":"Akyol","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.005_bb0010","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.pnpbp.2012.05.005_bb0015","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1192\/pb.21.4.224","article-title":"Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications","volume":"21","author":"Atkins","year":"1997","journal-title":"Psychiatr Bull"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.05.005_bb0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pnpbp.2007.08.003","article-title":"Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings","volume":"32","author":"Ben Othmen","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.05.005_bb0025","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","article-title":"Oxidative stress in schizophrenia: an integrated approach","volume":"35","author":"Bitanihirwe","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"10.1016\/j.pnpbp.2012.05.005_bb0030","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/schbul\/sbi028","article-title":"Significance and meaning of neurological signs in schizophrenia: two decades later","volume":"31","author":"Bombin","year":"2005","journal-title":"Schizophr Bull"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.05.005_bb0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/157015911795596595","article-title":"Oxidative stress in schizophrenia","volume":"9","author":"Bo\u0161kovi\u0107","year":"2011","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.05.005_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-1781(90)90103-C","article-title":"Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables","volume":"31","author":"Buckman","year":"1990","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2012.05.005_bb0045","series-title":"Methods of enzymatic analysis","first-page":"673","article-title":"Catalase","author":"Aebi","year":"1974"},{"issue":"5","key":"10.1016\/j.pnpbp.2012.05.005_bb0050","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.neubiorev.2008.01.005","article-title":"Neurological soft signs as candidate endophenotypes for schizophrenia: a shooting star or a Northern star?","volume":"32","author":"Chan","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"10.1016\/j.pnpbp.2012.05.005_bb0055","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/schbul\/sbp011","article-title":"Neurological soft signs in schizophrenia: a meta-analysis","volume":"36","author":"Chan","year":"2010","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2012.05.005_bb0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/0019-5545.39753","article-title":"Evaluation of antioxidant deficit in schizophrenia","volume":"50","author":"Dadheech","year":"2008","journal-title":"Indian J Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.05.005_bb0065","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/oxfordjournals.schbul.a007075","article-title":"Neurological soft signs and their relationship to cognitive and clinical efficacy of atypical antipsychotics in schizophrenia","volume":"30","author":"Das","year":"2004","journal-title":"Schizophr Bull"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.05.005_bb0070","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.conb.2009.05.001","article-title":"Redox dysregulation, neurodevelopment, and schizophrenia","volume":"19","author":"Do","year":"2009","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.pnpbp.2012.05.005_bb0075","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0013-7006(06)76151-6","article-title":"Oxidative stress involvement in schizophrenia pathophysiology: a review","volume":"32","author":"Fendri","year":"2006","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.pnpbp.2012.05.005_bb0080","first-page":"444","article-title":"An improved coupled test procedure for glutathione peroxidase in blood","volume":"12","author":"Gunzler","year":"1974","journal-title":"Z Klin Biochem"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.05.005_bb0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.mp.4001558","article-title":"Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence","volume":"10","author":"Harrison","year":"2005","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.05.005_bb0090","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.pnpbp.2006.12.019","article-title":"Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population","volume":"31","author":"Hitzeroth","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.05.005_bb0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0920-9964(97)00151-5","article-title":"The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia","volume":"30","author":"Horrobin","year":"1998","journal-title":"Schizophr Res"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.05.005_bb0100","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/0019-5545.55084","article-title":"Fronto-temporal dysfunction in schizophrenia: a selective review","volume":"51","author":"John","year":"2009","journal-title":"Indian J Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2012.05.005_bb0105","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.pnpbp.2008.08.013","article-title":"Manganese superoxide dismutase gene Ala-9Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients","volume":"32","author":"Kang","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2012.05.005_bb0110","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1176\/appi.ajp.160.7.1298","article-title":"Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses","volume":"160","author":"Keshavan","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.05.005_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00334-6","article-title":"Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics","volume":"58","author":"Khan","year":"2002","journal-title":"Schizophr Res"},{"issue":"12","key":"10.1016\/j.pnpbp.2012.05.005_bb0120","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0035-3787(07)78400-X","article-title":"Neurological soft signs and schizophrenia: a review of current knowledge","volume":"163","author":"Krebs","year":"2007","journal-title":"Rev Neurol"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.05.005_bb0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0920-9964(99)00206-6","article-title":"Validation and factorial structure of a standardized neurological examination assessing neurological soft signs in schizophrenia","volume":"45","author":"Krebs","year":"2000","journal-title":"Schizophr Res"},{"issue":"4","key":"10.1016\/j.pnpbp.2012.05.005_bb0130","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.pnpbp.2010.03.026","article-title":"Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients","volume":"34","author":"Liu","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.05.005_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00023210-200317010-00004","article-title":"Oxidative mechanisms and tardive dyskinesia","volume":"17","author":"Lohr","year":"2003","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.pnpbp.2012.05.005_bb0140","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.freeradbiomed.2004.12.020","article-title":"Selective neuronal vulnerability and inadequate stress response in superoxide dismutase mutant mice","volume":"38","author":"Lynn","year":"2005","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.05.005_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-9964(95)00049-6","article-title":"Free radical pathology and antioxidant defense in schizophrenia: a review","volume":"19","author":"Mahadik","year":"1996","journal-title":"Schizophr Res"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.05.005_bb0150","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0278-5846(00)00181-0","article-title":"Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia","volume":"25","author":"Mahadik","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.05.005_bb0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09540260600581993","article-title":"Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia","volume":"18","author":"Mahadik","year":"2006","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.005_bb0160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","article-title":"Involvement of the superoxide anion radical in autoxidation of pyrogallol and a convenient assay for superoxide dismutase","volume":"47","author":"Markund","year":"1974","journal-title":"Eur J Biochem"},{"issue":"4","key":"10.1016\/j.pnpbp.2012.05.005_bb0165","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00406-008-0859-y","article-title":"Neurological soft signs in patients with schizophrenia and their unaffected siblings: frequency and correlates in two ethnic and socioeconomic distinct populations","volume":"259","author":"Mechri","year":"2009","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.05.005_bb0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbr.2008.12.038","article-title":"Oral supplementation with melon superoxide dismutase extract promotes antioxidant defences in the brain and prevents stress-induced impairment of spatial memory","volume":"200","author":"Nakajima","year":"2009","journal-title":"Behav Brain Res"},{"issue":"6","key":"10.1016\/j.pnpbp.2012.05.005_bb0175","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1017\/S1461145707008401","article-title":"Oxidative stress in psychiatric disorders: evidence base and therapeutic implications","volume":"11","author":"Ng","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.05.005_bb0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psychres.2006.04.011","article-title":"Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia","volume":"153","author":"Pae","year":"2007","journal-title":"Psychiatry Res"},{"issue":"4","key":"10.1016\/j.pnpbp.2012.05.005_bb0185","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jnr.20272","article-title":"Antioxidants are required during the early critical period, but not later, for neuronal survival","volume":"78","author":"Perry","year":"2004","journal-title":"J Neurosci Res"},{"issue":"4","key":"10.1016\/j.pnpbp.2012.05.005_bb0190","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pnpbp.2009.03.012","article-title":"Correlates between neurological soft signs and saccadic parameters in schizophrenia","volume":"33","author":"Picard","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2012.05.005_bb0195","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.pnpbp.2009.06.018","article-title":"Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients","volume":"33","author":"Raffa","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.005_bb0200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-244X-11-124","article-title":"Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients","volume":"11","author":"Raffa","year":"2011","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.05.005_bb0205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-1781(03)00220-8","article-title":"Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients","volume":"121","author":"Ranjekar","year":"2003","journal-title":"Psychiatry Res"},{"issue":"9","key":"10.1016\/j.pnpbp.2012.05.005_bb0210","first-page":"681","article-title":"Membrane lipid peroxidation and neurological signs in first episode psychosis","volume":"37","author":"Scheffer","year":"1995","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.005_bb0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extra-pyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2012.05.005_bb0220","series-title":"Statistical Package for the Social Sciences (SPSS) for Windows, version 10.0","author":"SPSS 10.0","year":"1994"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.05.005_bb0225","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0006-3223(99)00289-9","article-title":"Schizophrenia: genes and environment","volume":"47","author":"Tsuang","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.05.005_bb0230","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1034\/j.1600-0447.2003.00113.x","article-title":"Neurological soft signs in never-treated schizophrenia","volume":"108","author":"Venkatasubramanian","year":"2003","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2012.05.005_bb0235","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0074-7742(04)59012-8","article-title":"Membrane phospholipids and cytokine interaction in schizophrenia","volume":"59","author":"Yao","year":"2004","journal-title":"Int Rev Neurobiol"},{"issue":"4","key":"10.1016\/j.pnpbp.2012.05.005_bb0240","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00023210-200115040-00004","article-title":"Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications","volume":"15","author":"Yao","year":"2001","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.pnpbp.2012.05.005_bb0245","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11064-011-0605-0","article-title":"Effects of Cu, Zn-superoxide dismutase on cell proliferation and neuroblast differentiation in the mouse dentate gyrus","volume":"37","author":"Yoo","year":"2012","journal-title":"Neurochem Res"},{"issue":"1","key":"10.1016\/j.pnpbp.2012.05.005_bb0250","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pnpbp.2009.09.020","article-title":"Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and superoxide dismutase 2 (SOD2, MnSOD) genes","volume":"34","author":"Zai","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2012.05.005_bb0255","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0920-9964(02)00352-3","article-title":"Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements","volume":"62","author":"Zhang","year":"2003","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2012.05.005_bb0260","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.schres.2005.10.011","article-title":"Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics","volume":"81","author":"Zhang","year":"2006","journal-title":"Schizophr Res"},{"issue":"5","key":"10.1016\/j.pnpbp.2012.05.005_bb0265","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4088\/JCP.v68n0513","article-title":"Disrupted antioxidant enzyme activity and elevated lipid peroxidation products in schizophrenic patients with tardive dyskinesia","volume":"68","author":"Zhang","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.005_bb0270","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11427-010-0013-8","article-title":"A meta-analysis of oxidative stress markers in schizophrenia","volume":"53","author":"Zhang","year":"2010","journal-title":"Sci China Life Sci"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584612001078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584612001078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T03:26:11Z","timestamp":1542943571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584612001078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0278584612001078"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2012.05.005","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}